在人类骨质细胞分化期间的转录重编程识别了骨质细胞活动的调节者
Morten S Hansen1,2,3, Kaja Madsen1,2, Maria Price4,5
1Molecular Endocrinology Laboratory (KMEB), Department of Endocrinology, Odense University Hospital, DK-5000, Odense C, Denmark.
Bone research
|January 23, 2024
概括
了解人类骨质细胞分化中的基因调节是新骨质疏松症治疗的关键. 这项研究确定了特定的基因和参与骨再吸收的G蛋白结合受体,提供了潜在的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨质疏松症涉及由于骨质细胞形成和活性增强而增加的骨质再吸收.
- 需要新的抗骨质疏松疗法,需要更深入地了解骨质细胞分化的遗传调节.
研究的目的:
- 提供人类骨质细胞分化过程中转录重编程的概述.
- 通过了解骨质细胞中的基因调节来确定骨质疏松症的潜在治疗点.
主要方法:
- 骨干细胞与来自八名女性捐献者的CD14+单细胞进行了分化.
- 在分化过程中进行了RNA测序,以确定差异表达的基因.
- 使用了网络分析和体外G蛋白结合受体的药理学调制.
主要成果:
- 鉴定了8980个差异表达的基因,分为八个时间模式.
- 发现像filamin B (FLNB) 和LOX-1这样的基因可以预测骨质细胞吸收活性.
- 索马托斯塔丁受体2 (SSTR2) 和自由脂肪酸受体4 (FFAR4) 被确定为抗吸收G蛋白结合受体.
结论:
- 转录重编程发生在人类骨质细胞分化过程中.
- 在骨质疏松症治疗中,SSTR2和FFAR4是潜在的抗吸收标.
- FLNB和LOX-1可以作为骨质细胞活性的分子标记物.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Co-activators and Co-repressors
7.4K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
RNA Polymerase II Accessory Proteins
9.2K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.2K


